{"acute hepatic failure": 4.1, "acute kidney injury": 2.51, "ammonia increased": 8.07, "anaemia": 2.74, "ascites": 17.68, "autoimmune hepatitis": 3.53, "blood bilirubin increased": 5.44, "blood creatinine increased": 2.53, "bradycardia": 3.14, "cholangiocarcinoma": 20.43, "cognitive disorder": 2.17, "cryoglobulinaemia": 34.94, "disseminated intravascular coagulation": 2.44, "drug ineffective": 13.99, "drug interaction": 2.93, "drug resistance": 4.02, "encephalopathy": 7.19, "genotype drug resistance test positive": 243.58, "glomerular filtration rate decreased": 9.42, "haematemesis": 2.07, "haemorrhagic stroke": 2.56, "hepatic cancer": 33.77, "hepatic cancer recurrent": 312.27, "hepatic cirrhosis": 21.0, "hepatic encephalopathy": 26.46, "hepatic failure": 10.32, "hepatic lesion": 6.23, "hepatic mass": 23.63, "hepatic pain": 5.28, "hepatitis b reactivation": 29.77, "hepatitis c": 286.76, "hepatitis c virus test positive": 210.43, "hepatocellular carcinoma": 71.94, "hyperbilirubinaemia": 3.65, "immune system disorder": 2.91, "incorrect product administration duration": 6.16, "intentional dose omission": 5.16, "jaundice": 3.21, "liver transplant": 34.8, "lymphoma": 2.84, "mental status changes": 2.13, "metastases to lymph nodes": 3.72, "neoplasm malignant": 2.21, "oesophageal varices haemorrhage": 45.26, "paranoia": 3.14, "portal vein thrombosis": 7.02, "product use complaint": 7.65, "psychotic disorder": 2.61, "renal impairment": 3.36, "septic shock": 2.26, "subarachnoid haemorrhage": 4.1, "sudden death": 3.74, "therapeutic response unexpected": 2.91, "therapy cessation": 4.6, "therapy non-responder": 2.09, "treatment failure": 62.51, "treatment noncompliance": 6.13, "unevaluable event": 2.78, "upper gastrointestinal haemorrhage": 2.46, "varices oesophageal": 15.7, "viral load increased": 3.27, "viral mutation identified": 102.11, "virologic failure": 16.05}